These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10934297)
1. Prolongation of the insulinotropic action of glucagon-like peptide 1 by the dimethyl ester of succinic acid in an animal model of type-2 diabetes. Garcia-Martinez JA; Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Int J Mol Med; 2000 Sep; 6(3):319-21. PubMed ID: 10934297 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of the insulinotropic action of GLP-1 by succinic acid dimethyl ester in fed anaesthetized rats. García-Martínez JA; Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Horm Metab Res; 2000 Aug; 32(8):306-9. PubMed ID: 10983625 [TBL] [Abstract][Full Text] [Related]
3. Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid. Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Endocrine; 2001 Aug; 15(3):283-5. PubMed ID: 11762700 [TBL] [Abstract][Full Text] [Related]
4. Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model. Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Endocrine; 2001 Nov; 16(2):113-6. PubMed ID: 11887931 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of glucagon-like peptide 1 insulinotropic action by succinic acid dimethyl ester. Leclercq-Meyer V; Malaisse WJ Life Sci; 1996; 58(14):1195-9. PubMed ID: 8614271 [TBL] [Abstract][Full Text] [Related]
6. Potentiation by glutamic acid dimethyl ester of GLP-1 insulinotropic action in fed anaesthetized rats. Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Int J Mol Med; 2001 Nov; 8(5):531-2. PubMed ID: 11605022 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of GLP-1 insulinotropic action by a nonglucidic nutrient in the pancreas of diabetic GK rats. Leclercq-Meyer V; Malaisse WJ Biochem Mol Med; 1996 Oct; 59(1):87-90. PubMed ID: 8902200 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604 [TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409 [TBL] [Abstract][Full Text] [Related]
11. Synergistic insulinotropic effects of succinic acid dimethyl ester and exendin-4 in anaesthetized rats. Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ Int J Mol Med; 2001 Sep; 8(3):269-71. PubMed ID: 11494054 [TBL] [Abstract][Full Text] [Related]
12. Extrapancreatic action of truncated glucagon-like peptide-I in Otsuka Long-Evans Tokushima Fatty rats, an animal model for non-insulin-dependent diabetes mellitus. Mizuno A; Kuwajima M; Ishida K; Noma Y; Murakami T; Tateishi K; Sato I; Shima K Metabolism; 1997 Jul; 46(7):745-9. PubMed ID: 9225826 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326 [TBL] [Abstract][Full Text] [Related]
14. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Vilsbøll T; Krarup T; Madsbad S; Holst JJ Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441 [TBL] [Abstract][Full Text] [Related]